Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Boston Therapeutics
 More »

  • J&J Opens Boston Innovation Center, Strikes Additional Early...
    ... JJDC also invested in Vedanta Biosciences, a developer of therapeutics designed to ... The Boston center opens less than a month after J&J opened its California Innovation ...
    6-26-2013
  • 10 Industry-Venture Fund Alliances
    ... director, worldwide licensing for Merck & Co., said at the 2012 Boston Venture Forum . ... exclusivity or commitment by GSK and J&J to therapeutics being developed by the startups. ...
    6-20-2013
  • Exploring Exosomal RNA
    During the "International Society of Extracellular Vesicles" (ISEV) meeting held in Boston ... potential for use in diagnostics and therapeutics for cancer and other diseases, Life ...
    6-15-2013
  • Stockholm-Uppsala Region Ups the Ante
    As this would mean unseating the likes of Boston, MA, San Francisco and San Diego, CA, the ... Olink, Vivolux, a drug discovery firm focused on cancer therapeutics, and BioLamina. ...
    4-15-2013
  • People in the News
    Magovcevic-Liebisch, Ph.D. , as svp, head of corporate business development. Peter Sheehan, M.D. Boston Therapeutics appointed Peter Sheehan, M.D. , as consulting medical director. ...
    4-15-2013
  • Stockholm-Uppsala Region Ups the Ante
    As this would mean unseating the likes of Boston, MA, San Francisco and San Diego, CA, the ... Olink, Vivolux, a drug discovery firm focused on cancer therapeutics, and BioLamina. ...
    3-6-2013
  • Addressing Unmet Medical Needs with Complex Carbohydrate Chemistry
    Manchester, NH-based Boston Therapeutics developed this treatment under the name PAZ320 and it is currently being tested in clinical trials. Necrosis and Ischemia A separate ...
    2-28-2013
  • Getting FDA to Yes
    ... by Johnson & Johnson's Janssen Therapeutics unit; and Vertex Pharmaceuticals' ... biomedical industry, joined the Boston Consulting Group (BCG) in May to issue a ...
    1-8-2013
  • Top 25 M&A Deals of 2012
    Sept. 13 Premium: N/A #14. Avila Therapeutics Acquired by: Celgene Price: $925 ... Deal Completed: Dec. 11 Premium: 39% #6. Boston Biomedical Acquired by: Dainippon ...
    1-4-2013
  • Top 20 Venture Capital Firms
    ... Ventures Location(s): Palo Alto, CA, and Boston Fund size and status: $1.6 billion under ... Catabasis Pharmaceuticals, Five Prime Therapeutics, Hydra Biosciences, Portola ...
    12-17-2012
  • Companion Dx and Personalized Medicine
    Companion diagnostics, like the therapeutics they support, are pioneering personalized ... points out David O'Bryan, president, Boston Biomedical Consultants. "Margins tend to ...
    11-1-2012
  • The 10 Most Well-Connected People in Biotech
    ... Therapeutics, Board of Directors, November 2010-present LifeTech Boston, Finance Review Committee miRagen Therapeutics, Co-Founder and Chairman, Board of Directors, July ...
    10-29-2012
  • Prizes and Quackery Dominate iPS Cell News
    ... M.D., Ph.D., of the Children's Hospital Boston and Harvard Medical School, whose ... Developing Therapeutics iPierian of South San Francisco uses its knowledge and experience ...
    10-19-2012
  • Obesity Drug Developers Post Steady Gains
    ... well as the California Healthcare Institute (CHI) and The Boston Consulting Group (BCG). ... Another preclinical drug developer, Ember Therapeutics, has licensed from Dana-Farber ...
    9-5-2012
  • Biotech Collaborations with Academic Centers: A Conflict of Interest...
    is co-director of the hematology division at Brigham and Women's Hospital in Boston. ... role of business in bringing new products [including novel therapeutics] to people. Dr. ...
    8-13-2012

  • Journal Articles

  • Improving the Management of Diabetes in Hospitalized Patients...
    Anand Vaidya, Shelley Hurwitz, Maria Yialamas, Le Min, Rajesh Garg
    Diabetes Technology & Therapeutics
    Training Program Diabetes Technology & Therapeutics Abstract Background: Poorly controlled ... at the Brigham and Women's Hospital (Boston, MA) in September 2009. House staff were ...
  • Design and Implementation of a Web-Based Patient Portal Linked...
    Richard W. Grant, Jonathan S. Wald, Eric G. Poon, Jeffrey L. Schnipper, Tejal K. Gandhi, Lynn A. Volk, Blackford Middleton
    Diabetes Technology & Therapeutics
    Diabetes Technology & Therapeutics Background: Despite the availability of expert ... Results: Partners HealthCare System (Boston, MA), a multi-hospital health care network ...
  • Wear and Biomechanical Characteristics of a Novel Shear-Reducing...
    Lawrence A. Lavery, Dan R. Lanctot, George Constantinides, Ruben G. Zamorano, Kyriacos A. Athanasiou, C. Mauli Agrawal
    Diabetes Technology & Therapeutics
    with Diabetes Diabetes Technology & Therapeutics Objective: This study was designed to ... We used the F-Scan® (Tekscan, Inc., Boston, MA) to determine in-shoe foot pressures and ...
  • Impact of MyCareTeam (tm) for Poorly Controlled Diabetes Mellitus
    Karen E. Smith, Betty A. Levine, Stephen C. Clement, Ming-Jye Hu, Adil Alaoui, Seong K. Mun
    Diabetes Technology & Therapeutics
    Diabetes Technology & Therapeutics Objective: Web-based diabetes management can be used to ... A larger randomized control trial is under way at the Boston Veterans Administration ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll